This brand name is authorized in Estonia, Lithuania, Mexico, Poland, Spain.
The drug DURACEF contains one active pharmaceutical ingredient (API):
1
|
UNII
280111G160 - CEFADROXIL
|
|
Cefadroxil is a cephalosporin for oral administration which inhibits bacterial wall synthesis of actively dividing cells by binding to one or more penicillin-binding proteins. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01DB05 | Cefadroxil | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DB First-generation cephalosporins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1025064, 1027101, 1027134, 1067318, 1067341, 1067352 |
| ES | Centro de información online de medicamentos de la AEMPS | 55730, 55731 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1002997, 1002998, 1002999, 1004085 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 90253 |
| PL | Rejestru Produktów Leczniczych | 100020850, 100020873, 100020910, 100080852 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.